Cargando…
Cellular Immunity in COVID-19 Convalescents with PCR-Confirmed Infection but with Undetectable SARS-CoV-2–Specific IgG
We investigated immune responses against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) among a group of convalescent, potential blood donors in Germany who had PCR-confirmed SARS-CoV-2 infection. Sixty days after onset of symptoms, 13/78 (17%) study participants had borderline or nega...
Autores principales: | , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Centers for Disease Control and Prevention
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7774536/ http://dx.doi.org/10.3201/eid2701.203772 |
_version_ | 1783630286233272320 |
---|---|
author | Schwarzkopf, Sina Krawczyk, Adalbert Knop, Dietmar Klump, Hannes Heinold, Andreas Heinemann, Falko M. Thümmler, Laura Temme, Christian Breyer, Marianne Witzke, Oliver Dittmer, Ulf Lenz, Veronika Horn, Peter A. Lindemann, Monika |
author_facet | Schwarzkopf, Sina Krawczyk, Adalbert Knop, Dietmar Klump, Hannes Heinold, Andreas Heinemann, Falko M. Thümmler, Laura Temme, Christian Breyer, Marianne Witzke, Oliver Dittmer, Ulf Lenz, Veronika Horn, Peter A. Lindemann, Monika |
author_sort | Schwarzkopf, Sina |
collection | PubMed |
description | We investigated immune responses against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) among a group of convalescent, potential blood donors in Germany who had PCR-confirmed SARS-CoV-2 infection. Sixty days after onset of symptoms, 13/78 (17%) study participants had borderline or negative results to an ELISA detecting IgG against the S1 protein of SARS-CoV-2. We analyzed participants with PCR-confirmed infection who had strong antibody responses (ratio >3) as positive controls and participants without symptoms of SARS-CoV-2 infection and without household contact with infected patients as negative controls. Using interferon-γ ELISpot, we observed that 78% of PCR-positive volunteers with undetectable antibodies showed T cell immunity against SARS-CoV-2. We observed a similar frequency (80%) of T-cell immunity in convalescent donors with strong antibody responses but did not detect immunity in negative controls. We concluded that, in convalescent patients with undetectable SARS-CoV-2 IgG, immunity may be mediated through T cells. |
format | Online Article Text |
id | pubmed-7774536 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Centers for Disease Control and Prevention |
record_format | MEDLINE/PubMed |
spelling | pubmed-77745362021-01-01 Cellular Immunity in COVID-19 Convalescents with PCR-Confirmed Infection but with Undetectable SARS-CoV-2–Specific IgG Schwarzkopf, Sina Krawczyk, Adalbert Knop, Dietmar Klump, Hannes Heinold, Andreas Heinemann, Falko M. Thümmler, Laura Temme, Christian Breyer, Marianne Witzke, Oliver Dittmer, Ulf Lenz, Veronika Horn, Peter A. Lindemann, Monika Emerg Infect Dis Research We investigated immune responses against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) among a group of convalescent, potential blood donors in Germany who had PCR-confirmed SARS-CoV-2 infection. Sixty days after onset of symptoms, 13/78 (17%) study participants had borderline or negative results to an ELISA detecting IgG against the S1 protein of SARS-CoV-2. We analyzed participants with PCR-confirmed infection who had strong antibody responses (ratio >3) as positive controls and participants without symptoms of SARS-CoV-2 infection and without household contact with infected patients as negative controls. Using interferon-γ ELISpot, we observed that 78% of PCR-positive volunteers with undetectable antibodies showed T cell immunity against SARS-CoV-2. We observed a similar frequency (80%) of T-cell immunity in convalescent donors with strong antibody responses but did not detect immunity in negative controls. We concluded that, in convalescent patients with undetectable SARS-CoV-2 IgG, immunity may be mediated through T cells. Centers for Disease Control and Prevention 2021-01 /pmc/articles/PMC7774536/ http://dx.doi.org/10.3201/eid2701.203772 Text en https://creativecommons.org/licenses/by/4.0/This is a publication of the U.S. Government. This publication is in the public domain and is therefore without copyright. All text from this work may be reprinted freely. Use of these materials should be properly cited. |
spellingShingle | Research Schwarzkopf, Sina Krawczyk, Adalbert Knop, Dietmar Klump, Hannes Heinold, Andreas Heinemann, Falko M. Thümmler, Laura Temme, Christian Breyer, Marianne Witzke, Oliver Dittmer, Ulf Lenz, Veronika Horn, Peter A. Lindemann, Monika Cellular Immunity in COVID-19 Convalescents with PCR-Confirmed Infection but with Undetectable SARS-CoV-2–Specific IgG |
title | Cellular Immunity in COVID-19 Convalescents with PCR-Confirmed Infection but with Undetectable SARS-CoV-2–Specific IgG |
title_full | Cellular Immunity in COVID-19 Convalescents with PCR-Confirmed Infection but with Undetectable SARS-CoV-2–Specific IgG |
title_fullStr | Cellular Immunity in COVID-19 Convalescents with PCR-Confirmed Infection but with Undetectable SARS-CoV-2–Specific IgG |
title_full_unstemmed | Cellular Immunity in COVID-19 Convalescents with PCR-Confirmed Infection but with Undetectable SARS-CoV-2–Specific IgG |
title_short | Cellular Immunity in COVID-19 Convalescents with PCR-Confirmed Infection but with Undetectable SARS-CoV-2–Specific IgG |
title_sort | cellular immunity in covid-19 convalescents with pcr-confirmed infection but with undetectable sars-cov-2–specific igg |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7774536/ http://dx.doi.org/10.3201/eid2701.203772 |
work_keys_str_mv | AT schwarzkopfsina cellularimmunityincovid19convalescentswithpcrconfirmedinfectionbutwithundetectablesarscov2specificigg AT krawczykadalbert cellularimmunityincovid19convalescentswithpcrconfirmedinfectionbutwithundetectablesarscov2specificigg AT knopdietmar cellularimmunityincovid19convalescentswithpcrconfirmedinfectionbutwithundetectablesarscov2specificigg AT klumphannes cellularimmunityincovid19convalescentswithpcrconfirmedinfectionbutwithundetectablesarscov2specificigg AT heinoldandreas cellularimmunityincovid19convalescentswithpcrconfirmedinfectionbutwithundetectablesarscov2specificigg AT heinemannfalkom cellularimmunityincovid19convalescentswithpcrconfirmedinfectionbutwithundetectablesarscov2specificigg AT thummlerlaura cellularimmunityincovid19convalescentswithpcrconfirmedinfectionbutwithundetectablesarscov2specificigg AT temmechristian cellularimmunityincovid19convalescentswithpcrconfirmedinfectionbutwithundetectablesarscov2specificigg AT breyermarianne cellularimmunityincovid19convalescentswithpcrconfirmedinfectionbutwithundetectablesarscov2specificigg AT witzkeoliver cellularimmunityincovid19convalescentswithpcrconfirmedinfectionbutwithundetectablesarscov2specificigg AT dittmerulf cellularimmunityincovid19convalescentswithpcrconfirmedinfectionbutwithundetectablesarscov2specificigg AT lenzveronika cellularimmunityincovid19convalescentswithpcrconfirmedinfectionbutwithundetectablesarscov2specificigg AT hornpetera cellularimmunityincovid19convalescentswithpcrconfirmedinfectionbutwithundetectablesarscov2specificigg AT lindemannmonika cellularimmunityincovid19convalescentswithpcrconfirmedinfectionbutwithundetectablesarscov2specificigg |